MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    A perception of knowledge on Parkinson’s disease among University students

    K. Gohain, M. Changmai (Shah Alam, Malaysia)

    Objective: The objective of this study is to understand the extent of awareness among the respondents on signs, symptoms, and management of Parkinson’s disease. Background:…
  • MDS Virtual Congress 2021

    Prevalence of Parkinsonism and Parkinson Disease in urban and rural populations in Latin America.

    J. Llibre-Guerra, M. Prina, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, A. Rodriguez-Salgado, J. Llibre-Guerra, G. Peters, I. Acosta, J. Juncos, J. Llibre-Rodriguez (La Habana, Cuba)

    Objective: To estimate the prevalence and risk factors of parkinsonism and Parkinson Disease in elderly individuals from Latin America. Background: Parkinson’ s disease (PD) is…
  • MDS Virtual Congress 2021

    The prevalence and types of postural deformities in Thai patients with Parkinson’s disease: A single-center study

    M. Vichutavate, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To address overall prevalence of Postural deformities(PostD) and each type of PostD (AC, TC, UC, and PS) in PD and healthy volunteers (HVs) Background:…
  • MDS Virtual Congress 2021

    Psychogenic movement disorders precipitated by post-lockdown return to school in adolescents: case series from Kenya

    D. Sokhi, K. Oyieke, P. Samia (Nairobi, Kenya)

    Objective: To describe three cases who presented with new-onset psychogenic movement disorders (PMD) after returning to school when the national lockdown was lifted. Background: PMD…
  • MDS Virtual Congress 2021

    Impaired saccadic inhibition in Huntington mutation carriers

    P. Ellmerer, F. Carbone, B. Heim, M. Ritter, M. Peball, S. Spielberger, K. Seppi, A. Djamshidian (Innsbruck, Austria)

    Objective: To assess saccadic paradigms in asymptomatic Huntington disease mutation carriers. Background: Huntington’s disease (HD) is characterized by motor, cognitive and behavioural abnormalities, such as…
  • MDS Virtual Congress 2021

    Validation of smartphone-based active tests with structural neuroimaging in Huntington’s disease

    J. Rennig, S. Holiga, D. Hawellek, F. Lipsmeier, J. Dorn, S. Schobel, C. Simillion, M. Lindemann (Basel, Switzerland)

    Objective: Explore the association of smartphone-based active tests in the Roche Huntington’s disease (HD) Digital Monitoring Platform (dMP) with brain imaging. Background: Remote digital monitoring…
  • MDS Virtual Congress 2021

    Intergenerational repeat instability of TTTCA expansions in SAMD12 might be the major cause of the genetic anticipation in familial cortical myoclonic tremor with epilepsy

    ZD. Cen, XH. Chen, HT. Wang, DH. Yang, F. Zhang, Y. Chen, S. Chen, LB. Wang, P. Liu, F. Xie, B. Wang (Hangzhou, China)

    Objective: To delineate and analyze the relationship between genetic and clinical features in 78 patients from 23 familial cortical myoclonic tremor with epilepsy type 1 (FCMTE1) pedigrees. Background:…
  • MDS Virtual Congress 2021

    Cerebellar bioenergetic depletion following ubiquinol supplementation in a patient with COQ8A-related ataxia

    J. Prasuhn, M. Göttlich, B. Ebeling, C. Bodemann, S. Großer, I. Wellach, K. Reuther, H. Hanssen, N. Brüggemann (Lübeck, Germany)

    Objective: To non-invasively map the individual treatment response in a patient with COQ8A-related ataxia following coenzyme Q10 supplementation. Background: Primary coenzyme Q10 (CoQ10) deficiency is…
  • MDS Virtual Congress 2021

    Utility of neurophysiological evaluation in movement disorders clinical practice

    T. Grippe, R. Chen (Toronto, Canada)

    Objective: To retrospectively evaluate the indications and final diagnoses of movement disorder neurophysiological evaluations in a specialized movement disorders centre. Background: The use of neurophysiological…
  • MDS Virtual Congress 2021

    “I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

    P. Hobson, V. Adhiyaman (Rhyl, United Kingdom)

    Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley